Robert W Cross

Title: The Innovations of Robert W. Cross

Introduction

Robert W. Cross is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of virology, particularly in the development of recombinant viral vectors. With a total of 2 patents, his work has implications for vaccine development and infectious disease research.

Latest Patents

One of his latest patents is titled "Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen." This invention focuses on compositions and methods related to recombinant vesicular stomatitis virus vectors (ΔGrVSV) that encode the Crimean-Congo Hemorrhagic Fever glycoprotein precursor (CCHFV-GPC). The patent outlines the formation of a recombinant vesicular stomatitis virus vector that can be utilized in vaccine development.

Another significant patent by Robert W. Cross is for a "Variant angola marburg virus." This invention includes methods for creating a uniformly lethal filovirus for outbred small mammals. The process involves mutating the viral genome through serial passages in small mammals, which can lead to advancements in understanding viral lethality and potential treatments.

Career Highlights

Robert W. Cross is affiliated with the University of Texas System, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding of viral diseases and developing innovative solutions to combat them.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues such as Chad E. Mire and Thomas W. Geisbert. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Robert W. Cross is a distinguished inventor whose work in virology has led to important advancements in the field. His patents reflect a dedication to innovation and a commitment to improving public health through scientific research.